Thursday, December 13, 2012

Targeted failure of the week. Post No 33. Avastin again! This time for colon cancer


Adding the pricey cancer drug Avastin to standard chemotherapy for earlier-stage colon cancer does not extend patients' lives, a new clinical trial finds.
Posted by at
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)